SUSMED,Inc. (4263) Stock Statistics & Valuation Metrics

SUSMED,Inc. has a market cap or net worth of ¥15.02B. The enterprise value is ¥5.37B.

SUSMED,Inc. has 16,822,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

SUSMED,Inc.’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -6.87%.

The current PE Ratio of SUSMED,Inc. is ―. SUSMED,Inc.’s PEG ratio is ―.

In the last 12 months, SUSMED,Inc. had revenue of 462.99M and earned -298.40M in profits. Earnings per share was -17.77.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

SUSMED,Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

SUSMED,Inc. upcoming earnings date is Nov 7, 2025, TBA (Confirmed).

SUSMED,Inc. as a current ratio of 35.43, with Debt / Equity ratio of 0.00%

In the past 12 months, SUSMED,Inc. has paid 1.21M in taxes.

SUSMED,Inc. EV to EBITDA ratio is -20.27, with an EV/FCF ratio of -13.42.

SUSMED,Inc. has ¥4.54B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -¥4.54B billion.

Gross margin is 97.36%, with operating margin of -64.68%, and net profit margin of -64.45%.

The average price target for SUSMED,Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―